5Broadway DC, Grierson I, O' Brien C, Hitchings RA. Adverse effects of topical antiglaucomatous medications, II : the outcome of filtration surgery [ J]. Arch Ophthalmol 1994 ; 112 : 1446-1454.
6Eleftheriadis H, Cheong M, Sandeman S. Corneal toxicity secondary to inadvertent use of benzalkontum chloride preserved viscoelastic material in cataract surgery[ J ]. Br J Oph thalmol 2002 ; 86 : 299-305.
8Herbst RA, Uter W,Pirker C,Findlay C. Allergic and nonallergic periorbital dermatitis:patch test results of the information network of the departments of dermatology during a 5-year period [ J ]. CODEDG (Contact Dermatitis )2004;51:13-19.
9Pisella PJ, Pouliquen P, Baudouin C. Prevalence of octtlar symptoms and signs with preserved and preservative free glaucoma medication [ J ]. Br J Oph t halmol 2002;86:418.
10Guenoun JM,Baudottin C,Rat P,Pauly A,Warnet JM,Brignole BF. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells[ J]. Invest Ophthalmol Vis Sci 2005 ;46(7) :2444-2450.
